A study from Changsha highlights the importance of social support in stress management and self-care among people with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease, suggesting that psychosocial factors are vital for effective disease control.
A study published in DovePress suggests that stress management in people with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease may depend as much on social support as on the stress itself. In a sample of 299 inpatients at a tertiary hospital in Changsha, researchers found that higher perceived stress was linked to weaker self-management, while greater perceived social support was associated with better day-to-day care. The paper adds to a growing body of evidence that MASLD, formerly known as fatty liver disease, is closely tied to diabetes and can make long-term disease control more difficult. According to the American Diabetes Association, the two conditions are bidirectionally linked and carry higher risks of fibrosis, cirrhosis and cardiovascular complications.
The findings matter because MASLD is common in people with type 2 diabetes. The Indian Health Service says recent studies have found MASLD in as many as 65% of people with type 2 diabetes, while a review indexed in PubMed highlights the role of insulin resistance, dyslipidaemia, chronic inflammation and mitochondrial dysfunction in driving disease progression. MedlinePlus Genetics notes that MASLD is a progressive liver condition that can advance to cirrhosis and liver cancer if not addressed, reinforcing the need for early detection and sustained management.
In the Changsha study, participants were mostly men, with a mean age of 56.9, and most were married and living in urban areas. The average stress score was 25.66, the average social support score was 56.05, and the average self-management score was 27.63, which the authors interpreted as a middling level with room for improvement. Education and income made a difference: people with higher educational attainment reported stronger social support and better self-management, while those earning at least 5,000 yuan a month tended to score higher on self-care.
The statistical analysis showed that stress and support moved in opposite directions. Patients who felt more stressed reported less support and poorer self-management, while those who felt more supported managed their condition more effectively. The researchers found that social support partly explained the relationship between stress and self-management, accounting for just over half of the total effect. In practical terms, that means stress does not only undermine self-care directly; it also appears to do so by eroding the sense of support patients feel from family, friends and other sources.
The authors say the results support a wider shift in chronic disease care towards psychosocial treatment alongside medical advice. They argue that clinicians should screen more actively for stress, strengthen family involvement, and build peer and community support into routine follow-up. They also note limits to the work: it was based on convenience sampling at a single hospital, used self-reported questionnaires and could not prove cause and effect. Even so, the study points to a clear lesson: for patients living with both diabetes and MASLD, better self-management may depend on more than instruction alone.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
